NASDAQ:BCDA

Biocardia Stock News

Healthcare > Biotechnology

Buy BCDA

*Your capital is at risk

$0.82

+0.0531 (+6.89%)

At Close: Jul 31, 2026

BioCardia (NASDAQ:BCDA) Coverage Initiated by Analysts at Alliance Global Partners

03:26am, Tuesday, 22'nd Sep 2020

Alliance Global Partners initiated coverage on shares of BioCardia (NASDAQ:BCDA) in a report released on Monday morning, Stock Target Advisor reports. The brokerage issued a buy rating and a $11.50 pr

BioCardia Reports Second Quarter 2020 Financial Results and Business Highlights

11:00am, Thursday, 13'th Aug 2020

SAN CARLOS, Calif., Aug. 13, 2020 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today reporte

BioCardia, Inc. (BCDA) May Report Negative Earnings: Know the Trend Ahead of Q2 Release

04:30pm, Wednesday, 12'th Aug 2020

BioCardia, Inc. (BCDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BioCardia To Conduct Mid-Year Conference Call and Corporate Update August 13, 2020

12:00pm, Friday, 07'th Aug 2020

SAN CARLOS, Calif., Aug. 07, 2020 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced

LD Micro - Announces Preliminary List of Presenters for the LD-500.

03:15pm, Wednesday, 05'th Aug 2020

LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively onlin

Innate Pharma (OTCMKTS:IPHYF) & BioCardia (OTCMKTS:BCDA) Financial Contrast

03:00am, Tuesday, 04'th Aug 2020

Innate Pharma (OTCMKTS:IPHYF) and BioCardia (OTCMKTS:BCDA) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their ana

How Much Is BioCardia, Inc. (NASDAQ:BCDA) Paying Its CEO?

10:51am, Wednesday, 22'nd Jul 2020

Peter Altman became the CEO of BioCardia, Inc. (NASDAQ:BCDA) in 2002, and we think it's a good time to look at the...

I-Mab (NASDAQ:BDTX) and BioCardia (NASDAQ:BCDA) Financial Survey

02:04am, Tuesday, 07'th Jul 2020

I-Mab (NASDAQ:BDTX) and BioCardia (OTCMKTS:BCDA) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, divi

BioCardia Announces Activation of Pivotal Trial Studying CardiAMP Cell Therapy Trial to Treat Chronic Myocardial Ischemia

02:20pm, Wednesday, 01'st Jul 2020

The purpose of the study is to determine the safety and efficacy of CardiAMP cell therapy in the treatment of patients with refractory angina pectoris and CMI. The FDA has said that the trial qualifi

BIOCARDIA, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K) | MarketScreener

09:11pm, Friday, 19'th Jun 2020

The Daily Biotech Pulse: Eloxx Resumes Cystic Fibrosis Study, Rexahn's Reverse Merger, Ultragenyx, Epizyme Await FDA Decisions

12:00am, Thursday, 18'th Jun 2020

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 17) Adverum Biotechnologies Inc...

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by